Mimedx Group Inc (NASDAQ: MDXG) on Tuesday, plunged -0.39% from the previous trading day, before settling in for the closing price of $7.62. Within the past 52 weeks, MDXG’s price has moved between $5.57 and $9.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -1.19% annually for the last half of the decade. The company achieved an average annual earnings per share of -18.02%. With a float of $115.40 million, this company’s outstanding shares have now reached $146.23 million.
In an organization with 895 employees, it is important to assess its efficiency.
Mimedx Group Inc (MDXG) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mimedx Group Inc is 21.82%, while institutional ownership is 44.62%. The most recent insider transaction that took place on Mar 13 ’24, was worth 162,029. In this transaction General Counsel and CAO of this company sold 20,381 shares at a rate of $7.95, taking the stock ownership to the 479,959 shares. Before that another transaction happened on Feb 20 ’24, when Company’s Chief Operating Officer sold 15,271 for $8.01, making the entire transaction worth $122,351. This insider now owns 401,050 shares in total.
Mimedx Group Inc (MDXG) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -18.02% per share during the next fiscal year.
Mimedx Group Inc (NASDAQ: MDXG) Trading Performance Indicators
Mimedx Group Inc (MDXG) is currently performing well based on its current performance indicators. A quick ratio of 2.71 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.35. Likewise, its price to free cash flow for the trailing twelve months is 33.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.46, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.38 in one year’s time.
Technical Analysis of Mimedx Group Inc (MDXG)
Let’s dig in a bit further. During the last 5-days, its volume was 0.67 million. That was inferior than the volume of 0.75 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 70.87%. Additionally, its Average True Range was 0.25.
During the past 100 days, Mimedx Group Inc’s (MDXG) raw stochastic average was set at 69.78%, which indicates a significant increase from 66.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.93% in the past 14 days, which was lower than the 44.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.19, while its 200-day Moving Average is $7.44. However, in the short run, Mimedx Group Inc’s stock first resistance to watch stands at $7.83. Second resistance stands at $8.06. The third major resistance level sits at $8.20. If the price goes on to break the first support level at $7.45, it is likely to go to the next support level at $7.31. Assuming the price breaks the second support level, the third support level stands at $7.07.
Mimedx Group Inc (NASDAQ: MDXG) Key Stats
Market capitalization of the company is 1.12 billion based on 147,604K outstanding shares. Right now, sales total 321,480 K and income totals 58,230 K. The company made 84,710 K in profit during its latest quarter, and 9,260 K in sales during its previous quarter.
